<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45764">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510482</url>
  </required_header>
  <id_info>
    <org_study_id>METC 15-2-023</org_study_id>
    <nct_id>NCT02510482</nct_id>
  </id_info>
  <brief_title>Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis</brief_title>
  <official_title>Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Calcified aortic valve stenosis (CAVS) is a progressive disease and nowadays, the
      cornerstone in diagnostics and follow-up is echocardiography. Cardiac biomarkers (such as
      cardiac troponins T and I and NT-pro-BNP) hold promise to fulfil a role in early recognition
      of complications concerning the aortic valve and decompensation. For this purpose, it is
      important to assess the normal biological variation (BV) of cardiac biomarkers in CAVS. The
      assessment of biological variation will contribute to a better understanding of fluctuation
      of cardiac biomarkers in subjects with stable CAVS. These data will improve monitoring of
      CAVS using cardiac biomarkers.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac troponin T</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac troponin I</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NT-pro-BNP</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Aortic valve stenosis</arm_group_label>
    <description>Individuals with clinically stable moderate aortic valve stenosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>Aortic valve stenosis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals with clinically stable moderate aortic valve stenosis
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinically stable moderate aortic valve stenosis

          -  No evidence of acute cardiovascular disease

        Exclusion Criteria:

          -  Acute myocardial infarction in the last six months

          -  Pulmonary embolism in the last six months

          -  Hospitalisation for heart failure in the last six months

          -  Chronic kidney disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht University Medical Center</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Klinkenberg LJ, van Dijk JW, Tan FE, van Loon LJ, van Dieijen-Visser MP, Meex SJ. Circulating cardiac troponin T exhibits a diurnal rhythm. J Am Coll Cardiol. 2014 May 6;63(17):1788-95. doi: 10.1016/j.jacc.2014.01.040. Epub 2014 Feb 26.</citation>
    <PMID>24583293</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>March 21, 2017</lastchanged_date>
  <firstreceived_date>July 27, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cardiac biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
